Skip to content

Pulmonary Specialist-Health Coach Consult Model Study

Pulmonary Specialist-Health Coach Consult (PuSHCon) Model to Improve Access to Specialist Consultation and Receipt of Recommended Evidence-based Care for Vulnerable Patients With Chronic Obstructive Pulmonary Disease (COPD) and Asthma

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03695276
Acronym
PuSHCon
Enrollment
328
Registered
2018-10-04
Start date
2020-10-20
Completion date
2025-01-31
Last updated
2025-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD Asthma

Keywords

Health coaching, COPD, Asthma, Access to specialty care

Brief summary

The Pulmonary Specialist-Health Coach Consultation (PuSHCon) study examines the implementation of health coach-assisted consultations to improve access to specialist care and implementation of specialist recommendations for patients with COPD, asthma, and asthma COPD overlap syndrome (ACOS) for low-income and vulnerable patients seen at public health clinics. Three hundred sixty (360) patients from ten clinics will be enrolled in the study and randomized at the individual level to receive health coaching or usual care; 180 patients will receive usual care and 180 patients will receive the PuSHCon model.

Detailed description

While evidence-based care for chronic obstructive pulmonary disease (COPD) and asthma can substantially reduce disease burden and prevent emergency visits and hospitalizations, it is estimated that 55% of patients with COPD do not receive all recommended care and that less than 50% of patients with asthma are well controlled. The proposed study will evaluate the effectiveness of a novel model for pulmonary specialist-health coach consultations (PuSHCon) in its ability to increase access to specialty recommendations and the provision of evidence-based care for patients with chronic obstructive pulmonary disease (COPD) and/or asthma receiving care at federally qualified health centers (FQHCs). The specific aims of the study are to compare the use of evidence-based care and of patient reported outcomes 4 months after the consultation. In addition, the study will evaluate the cost per patient in each model to determine the model's effectiveness in increasing access and lowering cost. The first aim of comparing the use of evidence-based care will be measured as the proportion of guideline-based recommendations that are ultimately received by the patients. The secondary endpoint for this aim will be measured through the proportion of patients receiving guideline-concordant medications at 4 months after consultation compared to baseline. The second aim of the study regarding patient-reported outcomes will be measured primarily through the change in COPD and/or asthma related quality of life measures from baseline to 4 months post consultation. The secondary measure for this aim will look at changes in COPD and/or asthma specific symptom scores. The third aim of the study is to assess the impact of this model on access to care and cost of care. Access will be measured by tracking the number of patients who successfully complete a consultation per month. Costs will be determined by calculating time spent per patients, as well as by health care utilization.

Interventions

BEHAVIORALPushCon Model

Pulmonary specialist consultation facilitated by a trained health coach, who will gather information from the patient and medical record prior to the consultation and will using health coaching skills to support implementation of recommended care.

BEHAVIORALUsual care

The standard of care, which usually means management within primary care.

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Investigator)

Masking description

Investigators and the Data Safety Monitoring Board will receive data summaries that mask identification of groups.

Intervention model description

Randomized controlled trial, with randomization at the individual level

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* English or Spanish speaking * At least 18 years of age * Diagnosed with asthma or COPD * Experiencing uncontrolled symptoms or exacerbations

Exclusion criteria

* Do not plan to attend primary care clinic for at least 3 months * Already engaged in pulmonary specialty care (defined as at least one visit in last 12 months) * Cognitive dysfunction that would prevent interaction with a health coach * Not having a phone at which the participant can be reached

Design outcomes

Primary

MeasureTime frameDescription
Receipt of Recommended Care16 weeks after enrollmentNumerator: Number of guideline-based recommendations implemented by the patient; Denominator: Number of minimal recommendations based on GOLD/GINA guidelines
Receipt of Recommended Medications16 weeks after enrollmentNumerator: Number of people receiving all minimal recommended medications based on GOLD/GINA guidelines; Denominator: Number of people enrolled in study

Secondary

MeasureTime frameDescription
Medication Adherence16 weeks after enrollmentNumber and percentage of patients taking all controller inhalers as prescribed for at least 5 of the last 7 days
Patient-reported Quality of Care16 weeks after enrollmentMean score on Patient Assessment of Chronic Illness Care (PACIC) measure, with response options ranging from 1 (Almost never) to 5 (Almost Always). The scale is scored as an overall mean (1-5), with higher scores indicating a more frequent presence of high quality care. Four PACIC subscales (patient activation, delivery system practice design, goal setting/tailoring, problem solving/contextual), plus follow up/coordination are also represented by means of respective items.
Provider Acceptance of Recommended Care16 weeks after enrollmentNumber of guideline-based recommendations where provider took action (e.g., prescribed or referred patient for care); Denominator: Number of minimal recommendations based on GOLD/GINA guidelines
Proportion of Patients Who Engaged in Chronic Lung Disease Education16 weeks after enrollmentNumerator: Number of people who engage with at least one existing resources such as group education classes or pulmonary care; Denominator: Number of people enrolled in the study
Disease Specific Symptoms Score (COPD & Asthma)16 weeks after enrollmentScore on St. George's Respiratory questionnaire (symptom subscale) with range of 0-100, where 0 is highest quality of life and 100 is lowest. (Full scoring manual located at: http://www.healthstatus.sgul.ac.uk/SGRQ\_download/sgrq-c-manual-april-2012.pdf)
Patient-Reported Disease-specific Quality of Life (for Asthma and COPD) - Overall Score16 weeks after enrollmentScore on St. George's Respiratory questionnaire (overall) with range of 0-100, where 0 is highest quality of life and 100 is lowest. (Full scoring manual located at: http://www.healthstatus.sgul.ac.uk/SGRQ\_download/sgrq-c-manual-april-2012.pdf)

Countries

United States

Participant flow

Participants by arm

ArmCount
PuSHCon Model
A health coach will contact patients with poorly controlled asthma or COPD. The health coach will gather information from the patient and medical record and review the case with a pulmonary specialist. The specialist will provide recommendations to the primary care clinician based on the case review; the specialist may request an in-person patient visit if needed. The health coach will follow up with the primary care clinician and will support implementation of recommendations that the the primary care clinician accepts,
165
Usual Care
Patients with poorly controlled asthma or COPD will receive the standard of care, which usually means management within primary care. The study team will provide in-service sessions on COPD and asthma guidelines to primary care clinicians in both arms. As in standard practice, a primary care clinician may refer a patient for specialty consultation or diagnostic testing at any time.
163
Total328

Baseline characteristics

CharacteristicUsual CarePuSHCon ModelTotal
Age, Continuous53.1 Years
STANDARD_DEVIATION 14
51.9 Years
STANDARD_DEVIATION 13.6
52.5 Years
STANDARD_DEVIATION 13.8
Breathing-related quality of life52.0 Scores on a scale
STANDARD_DEVIATION 16.8
51.6 Scores on a scale
STANDARD_DEVIATION 16.6
51.8 Scores on a scale
STANDARD_DEVIATION 16.7
Ethnicity (NIH/OMB)
Hispanic or Latino
56 Participants59 Participants115 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
107 Participants106 Participants213 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants1 Participants2 Participants
Race (NIH/OMB)
Asian
9 Participants7 Participants16 Participants
Race (NIH/OMB)
Black or African American
63 Participants60 Participants123 Participants
Race (NIH/OMB)
More than one race
6 Participants12 Participants18 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
2 Participants3 Participants5 Participants
Race (NIH/OMB)
Unknown or Not Reported
63 Participants59 Participants122 Participants
Race (NIH/OMB)
White
19 Participants23 Participants42 Participants
Sex/Gender, Customized
Female
128 Participants118 Participants246 Participants
Sex/Gender, Customized
Male
34 Participants43 Participants77 Participants
Sex/Gender, Customized
Other
1 Participants4 Participants5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1650 / 163
other
Total, other adverse events
0 / 1650 / 163
serious
Total, serious adverse events
0 / 1650 / 163

Outcome results

Primary

Receipt of Recommended Care

Numerator: Number of guideline-based recommendations implemented by the patient; Denominator: Number of minimal recommendations based on GOLD/GINA guidelines

Time frame: 16 weeks after enrollment

ArmMeasureValue (MEAN)
PuSHCon ModelReceipt of Recommended Care38.2 Percentage of guidelines implemented
Usual CareReceipt of Recommended Care23.7 Percentage of guidelines implemented
Primary

Receipt of Recommended Medications

Numerator: Number of people receiving all minimal recommended medications based on GOLD/GINA guidelines; Denominator: Number of people enrolled in study

Time frame: 16 weeks after enrollment

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
PuSHCon ModelReceipt of Recommended Medications126 Participants
Usual CareReceipt of Recommended Medications110 Participants
Secondary

Disease Specific Symptoms Score (COPD & Asthma)

Score on St. George's Respiratory questionnaire (symptom subscale) with range of 0-100, where 0 is highest quality of life and 100 is lowest. (Full scoring manual located at: http://www.healthstatus.sgul.ac.uk/SGRQ\_download/sgrq-c-manual-april-2012.pdf)

Time frame: 16 weeks after enrollment

Population: Includes individuals who completed a 16 week survey

ArmMeasureValue (MEAN)Dispersion
PuSHCon ModelDisease Specific Symptoms Score (COPD & Asthma)40.8 Scores on a scaleStandard Deviation 21.1
Usual CareDisease Specific Symptoms Score (COPD & Asthma)49.7 Scores on a scaleStandard Deviation 21.2
Secondary

Medication Adherence

Number and percentage of patients taking all controller inhalers as prescribed for at least 5 of the last 7 days

Time frame: 16 weeks after enrollment

Population: Includes individuals who completed the 16 week survey and reported taking a controller medication at the time

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
PuSHCon ModelMedication Adherence48 Participants
Usual CareMedication Adherence42 Participants
Secondary

Patient-Reported Disease-specific Quality of Life (for Asthma and COPD) - Overall Score

Score on St. George's Respiratory questionnaire (overall) with range of 0-100, where 0 is highest quality of life and 100 is lowest. (Full scoring manual located at: http://www.healthstatus.sgul.ac.uk/SGRQ\_download/sgrq-c-manual-april-2012.pdf)

Time frame: 16 weeks after enrollment

Population: Includes individuals who completed the 16 week survey

ArmMeasureValue (MEAN)Dispersion
PuSHCon ModelPatient-Reported Disease-specific Quality of Life (for Asthma and COPD) - Overall Score37.6 Scores on a scaleStandard Deviation 18.6
Usual CarePatient-Reported Disease-specific Quality of Life (for Asthma and COPD) - Overall Score50.8 Scores on a scaleStandard Deviation 18.2
Secondary

Patient-reported Quality of Care

Mean score on Patient Assessment of Chronic Illness Care (PACIC) measure, with response options ranging from 1 (Almost never) to 5 (Almost Always). The scale is scored as an overall mean (1-5), with higher scores indicating a more frequent presence of high quality care. Four PACIC subscales (patient activation, delivery system practice design, goal setting/tailoring, problem solving/contextual), plus follow up/coordination are also represented by means of respective items.

Time frame: 16 weeks after enrollment

Population: Includes individuals who completed the 16 week survey

ArmMeasureValue (MEAN)Dispersion
PuSHCon ModelPatient-reported Quality of Care3.37 1-5 Likert Scale (5 best)Standard Deviation 1.11
Usual CarePatient-reported Quality of Care3.12 1-5 Likert Scale (5 best)Standard Deviation 1.12
Secondary

Proportion of Patients Who Engaged in Chronic Lung Disease Education

Numerator: Number of people who engage with at least one existing resources such as group education classes or pulmonary care; Denominator: Number of people enrolled in the study

Time frame: 16 weeks after enrollment

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
PuSHCon ModelProportion of Patients Who Engaged in Chronic Lung Disease Education126 Participants
Usual CareProportion of Patients Who Engaged in Chronic Lung Disease Education91 Participants
Secondary

Provider Acceptance of Recommended Care

Number of guideline-based recommendations where provider took action (e.g., prescribed or referred patient for care); Denominator: Number of minimal recommendations based on GOLD/GINA guidelines

Time frame: 16 weeks after enrollment

Population: Number of recommendations accepted out of those provided

ArmMeasureValue (COUNT_OF_UNITS)
PuSHCon ModelProvider Acceptance of Recommended Care2425 Recommendations

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026